Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Collegium Pharmaceutical missed estimated earnings by 53.33%, reporting an EPS of $0.42 versus an estimate of $0.9.
Revenue was down $3.97 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.55 which was followed by a 9.53% drop in the share price the next day.
Here's a look at Collegium Pharmaceutical's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.04 | 0.36 | 0.30 | |
| EPS Actual | -0.51 | 0.22 | 0.27 | 0.41 |
| Revenue Estimate | 81.61M | 84.89M | 84.77M | 81.87M |
| Revenue Actual | 27.36M | 78.84M | 82.94M | 87.72M |
To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
